Igama | Semaglutide |
Inombolo ye-CAS | I-910463-68-2 |
Ifomula yemolekyuli | I-C187h291N45O59 |
Ubunzima bemolekyuli | 4113.57754 |
Inombolo ye-einecs | 203-40-2 |
I-sermaglutide; I-Smaglutide fandokem; Ukungcola kwe-semaglutide; I-Sermaglutide USP / EP; I-semaglutide; I-Sermaglutiide caus 910463 68 2; I-Ozempic,
I-Semaglutide sisizukulwane esitsha se-GLP-1 UNovo Aldusk ugqibe izifundo ze-6 ISIQINISEKISO SESIQINISEKISO SESIFUNDO, kwaye ungenise isicelo sobhaliso olutsha lokubhaliswa kwe-semaglutide kwinaliti ye-SEMORKID kwi-US kwi-US kaDisemba.
Xa kuthelekiswa ne-liraglutide, semaglutide inesikhonkwane elide kunye ne-hydrophobiction, kodwa i-semaglutide iguqulwe nge-chain emfutshane ye-PEG, kwaye i-hydrophili- i-hydrophility iphuculwe kakhulu. Emva kokulungiswa kwe-PEG, ayinakukubopha ngokusondeleyo kwi-albhamun, gubungela indawo ye-hydrolysis ye-DPP-4, kodwa inciphise ukungcola, kwaye idlulise isiqingatha sendalo, kwaye sifezekise isiphumo sokujikeleza kwexesha.
I-Semaglutide yifomu ye-dosage ende ephuhliswe ngokusekwe kwimeko yesiseko ye-liraglutide, esebenza ngakumbi kunyango lwesifo seswekile 2.
I-Semaglutide (i-ryblessus, e-Ozempic, NN9535, i-OG2173-.
Kwinkqubo ngokubanzi, isiqinisekiso kunye nesiqinisekiso sisendaweni eligubungela yonke inqanaba lemveliso egqityiweyo. Ukusebenza okwaneleyo kunye nokulawula okufanelekileyo kwenziwa ngokuhambelana neenkqubo ezivunyiweyo / iinkcukacha. Guqula uLawulo kunye neNkqubo yokuPhathwa kweNtlalondi yendawo, kwaye kwenziwa uphando oluyimfuneko. Iinkqubo ezifanelekileyo zisendaweni yokuqinisekisa umgangatho wemveliso ngaphambi kokukhululwa kwintengiso.